Brenda B. Hoffman

1.5k total citations · 1 hit paper
10 papers, 1.3k citations indexed

About

Brenda B. Hoffman is a scholar working on Nephrology, Molecular Biology and Oncology. According to data from OpenAlex, Brenda B. Hoffman has authored 10 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Nephrology, 7 papers in Molecular Biology and 2 papers in Oncology. Recurrent topics in Brenda B. Hoffman's work include Chronic Kidney Disease and Diabetes (9 papers), TGF-β signaling in diseases (6 papers) and Pancreatic and Hepatic Oncology Research (2 papers). Brenda B. Hoffman is often cited by papers focused on Chronic Kidney Disease and Diabetes (9 papers), TGF-β signaling in diseases (6 papers) and Pancreatic and Hepatic Oncology Research (2 papers). Brenda B. Hoffman collaborates with scholars based in United States. Brenda B. Hoffman's co-authors include Fuad N. Ziyadeh, Kumar Sharma, Motohide Isono, Soon Won Hong, Sheldon Chen, Dong Cheol Han, Tracy McGowan, M. Carmen Iglesias‐de la Cruz, Dong Cheol Han and Yanqing Zhu and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Kidney International and Journal of the American Society of Nephrology.

In The Last Decade

Brenda B. Hoffman

10 papers receiving 1.3k citations

Hit Papers

Long-term prevention of renal insufficiency, excess matri... 2000 2026 2008 2017 2000 250 500 750

Peers

Brenda B. Hoffman
Janine LaPage United States
Elyce Ozols Australia
Nadia Abdel Wahab United Kingdom
Hyun Soon Lee South Korea
Weier Qi Australia
Sherif Youssef Australia
Brenda B. Hoffman
Citations per year, relative to Brenda B. Hoffman Brenda B. Hoffman (= 1×) peers Alejandra Droguett

Countries citing papers authored by Brenda B. Hoffman

Since Specialization
Citations

This map shows the geographic impact of Brenda B. Hoffman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brenda B. Hoffman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brenda B. Hoffman more than expected).

Fields of papers citing papers by Brenda B. Hoffman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brenda B. Hoffman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brenda B. Hoffman. The network helps show where Brenda B. Hoffman may publish in the future.

Co-authorship network of co-authors of Brenda B. Hoffman

This figure shows the co-authorship network connecting the top 25 collaborators of Brenda B. Hoffman. A scholar is included among the top collaborators of Brenda B. Hoffman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brenda B. Hoffman. Brenda B. Hoffman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Chen, Sheldon, Brenda B. Hoffman, Joseph S. Lee, et al.. (2004). Cultured tubule cells from TGF-β1 null mice exhibit impaired hypertrophy and fibronectin expression in high glucose. Kidney International. 65(4). 1191–1204. 29 indexed citations
2.
Hoffman, Brenda B., et al.. (2000). Increased urinary transforming growth factor- beta1 excretion in children with posterior urethral valves. Urology. 56(2). 311–314. 22 indexed citations
3.
Han, Dong Cheol, Brenda B. Hoffman, Soon Won Hong, Jia Guo, & Fuad N. Ziyadeh. (2000). Therapy with antisense TGF-β1 oligodeoxynucleotides reduces kidney weight and matrix mRNAs in diabetic mice. American Journal of Physiology-Renal Physiology. 278(4). F628–F634. 89 indexed citations
4.
Ziyadeh, Fuad N., Brenda B. Hoffman, Dong Cheol Han, et al.. (2000). Long-term prevention of renal insufficiency, excess matrix gene expression, and glomerular mesangial matrix expansion by treatment with monoclonal antitransforming growth factor-β antibody indb/dbdiabetic mice. Proceedings of the National Academy of Sciences. 97(14). 8015–8020. 790 indexed citations breakdown →
5.
Isono, Motohide, András Mogyorósi, Dong Cheol Han, Brenda B. Hoffman, & Fuad N. Ziyadeh. (2000). Stimulation of TGF-β type II receptor by high glucose in mouse mesangial cells and in diabetic kidney. American Journal of Physiology-Renal Physiology. 278(5). F830–F838. 66 indexed citations
6.
Han, Dong Cheol, Motohide Isono, Brenda B. Hoffman, & Fuad N. Ziyadeh. (1999). High Glucose Stimulates Proliferation and Collagen Type I Synthesis in Renal Cortical Fibroblasts. Journal of the American Society of Nephrology. 10(9). 1891–1899. 128 indexed citations
7.
Hoffman, Brenda B., Kumar Sharma, Yanqing Zhu, & Fuad N. Ziyadeh. (1998). Transcriptional activation of transforming growth factor-β1 in mesangial cell culture by high glucose concentration. Kidney International. 54(4). 1107–1116. 147 indexed citations
8.
Hoffman, Brenda B., Kumar Sharma, & Fuad N. Ziyadeh. (1998). Potential Role of TGF-β in Diabetic Nephropathy. PubMed. 24(2-3). 190–196. 59 indexed citations
9.
Hoffman, Brenda B. & Fuad N. Ziyadeh. (1996). The role of growth factors in the development of diabetic nephropathy. Current Opinion in Endocrinology & Diabetes. 3(4). 322–329. 2 indexed citations
10.
Hoffman, Brenda B. & Fuad N. Ziyadeh. (1995). Facilitative glucose transport proteins and sodium-glucose co-transporters in the kidney. Current Opinion in Nephrology & Hypertension. 4(5). 406–412. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026